Phase IC Study of Safety and PK of SQ109 300mg Daily

NCT01358162 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

OTHER: Placebo
DRUG: SQ109

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)